PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Takashi Akiba Selected Research

Renal Dialysis (Hemodialysis)

05/2008	Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.
04/2008	Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism.
02/2008	Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan.
01/2008	Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
06/2007	Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan.
04/2007	A case report of the effect of acetate-free biofiltration on arrhythmia in a hemodialysis patient.
04/2006	Prevalence of hepatitis E virus infection in regular hemodialysis patients.
12/2004	2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
06/2004	Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.
01/2004	Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients.
07/2002	Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
04/2002	Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
01/2002	Inflammation and resistance to erythropoietin in hemodialysis patients.

Articles by Research Topic

Disease

4	Chronic Kidney Failure (Chronic Renal Failure) 05/2007 - 07/2003
3	Secondary Hyperparathyroidism 04/2008 - 09/2004
3	Anemia 01/2008 - 12/2004
3	Kidney Diseases (Kidney Disease) 04/2005 - 05/2004
2	Infection 02/2008 - 04/2006
2	Orthostatic Hypotension (Postural Hypotension) 07/2002 - 04/2002
1	Arteriovenous Fistula 05/2008
1	Hypertension (High Blood Pressure) 06/2007
1	Hyperparathyroidism 05/2007
1	Cardiac Arrhythmias (Arrythmia) 04/2007
1	Osteoporosis 01/2007
1	Primary Hyperoxaluria (Oxaluria, Primary) 01/2006
1	Kidney Failure (Renal Failure) 11/2005
1	Hepatitis C 06/2004
1	Bone Diseases (Bone Disease) 05/2004
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2004
1	Sclerosis 01/2003
1	Inflammation 01/2002

Drug/Important Bio-Agent (IBA)

2	ErythropoietinIBA 01/2008 - 01/2002
2	Vitamin D FDA LinkGeneric 05/2007 - 09/2004
2	Hemoglobins (Hemoglobin)IBA 01/2005 - 07/2003
1	cinacalcet (Sensipar)FDA Link 04/2008
1	Biological Markers (Surrogate Marker)IBA 01/2007
1	Parathyroid Hormone (Parathormone)IBA 11/2005
1	maxacalcitolIBA 12/2004
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2004

Therapy/Procedure

13	Renal Dialysis (Hemodialysis) 05/2008 - 01/2002
2	Kidney Transplantation 01/2006 - 04/2005
2	Transplantation (Transplant Recipients) 09/2004 - 05/2004
1	Hemoperfusion 08/2004
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2003